CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and Progression

Overview of attention for article published in Neurology, November 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 12 news outlets
twitter: 6 X users
facebook: 2 Facebook pages

bluesky: 1 Bluesky user
podcasts: 2 podcasts

Readers on

mendeley: 17 Mendeley

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 126,315 followers.

RT @Neuroscope_mp: Here are some interesting papers that support this information https://t.co/hLaRVvFkRa https://t.co/qKZDYcZyfk https://…

Here are some interesting papers that support this information https://t.co/hLaRVvFkRa https://t.co/qKZDYcZyfk https://t.co/ItY27HmF3U

Read the related article in Neurology: https://t.co/gHqCajio6S

🧠 New Neurology research on CSF α-synuclein seed amplification assays & AD biomarkers in Dementia w/ Lewy Bodies highlights important insights into disease presentation & progression. Drs Berman & Lopez among others advancing biomarker scienc…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.